An engineered mutant of a host phospholipid synthesis gene inhibits viral replication without compromising host fitness.

Viral infections universally rely on numerous hijacked host factors to be successful. It is therefore possible to control viral infections by manipulating host factors that are critical for viral replication. Given that host genes may play essential roles in certain cellular processes， any successful manipulations for virus control should cause no or mild effects on host fitness. We previously showed that a group of positive-strand RNA viruses enrich phosphatidylcholine (PC) at the sites of viral replication. Specifically， brome mosaic virus (BMV) replication protein 1a interacts with and recruits a PC synthesis enzyme phosphatidylethanolamine methyltransferase， Cho2p， to the viral replication sites that are assembled on the perinuclear ER membrane. Deletion of the CHO2 gene inhibited BMV replication by 5-fold， however， slowed down cell growth as well. Here， we show that an engineered Cho2p mutant supports general PC synthesis and normal cell growth but blocks BMV replication. This mutant interacts and co-localizes with BMV 1a but prevents BMV 1a from localizing to the perinuclear ER membrane. The mislocalized BMV 1a fails to induce the formation of viral replication complexes. Our study demonstrates an effective antiviral strategy in which a host lipid synthesis gene is engineered to control viral replication without comprising host growth.